Upstream Bio Upstream Bio is a clinical-stage biotechnology company that develops treatments for inflammatory diseases. | ||
Founding Date | Founding Date 2009 | Founding Date 2021 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations Burnaby, CA HQ Porto, PT Manchester, GB | Locations Waltham, US HQ |
Employees | Employees N/A | Employees 38 |
Valuation ($) | Valuation ($) 401.7 k | Valuation ($) 1.3 b |
Financial | ||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $2.9m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $23m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit ($20.2m) (FY, 2025) |
Net income | Net income ($7.1m) (FY, 2022) | Net income ($143.4m) (FY, 2025) |
Upstream Bio is a clinical-stage biotechnology company that develops treatments for inflammatory diseases.
View company